Cargando…
Concomitant administration of sGC stimulators with common classes of anti-hypertensive agents results in increased efficacy in spontaneously hypertensive rats
Autores principales: | Germano, Peter, Tobin, Jenny, Jefferson, Robert, Shea, Courtney, Smith, Adaline, Jamie Im, G-Yoon, Sheppeck, James, Wakefield, James, Sykes, Kristie, Ribadeneira, Maria, Rivers, Samuel, Masferrer, Jaime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565123/ http://dx.doi.org/10.1186/2050-6511-16-S1-A54 |
Ejemplares similares
-
IWP-121: a novel sGC stimulator that reduces blood pressure and exhibits anti-fibrotic and anti-inflammatory activities in the Dahl Salt-Sensitive rat model
por: Shea, Courtney, et al.
Publicado: (2015) -
Olinciguat, an Oral sGC Stimulator, Exhibits Diverse Pharmacology Across Preclinical Models of Cardiovascular, Metabolic, Renal, and Inflammatory Disease
por: Zimmer, Daniel P., et al.
Publicado: (2020) -
Genetic modifiers of hypertension in sGC-deficient mice
por: Buys, Emmanuel
Publicado: (2013) -
SGLT2 inhibition potentiates the cardiovascular, renal, and metabolic effects of sGC stimulation in hypertensive rats with prolonged exposure to high-fat diet
por: Reverte, Virginia, et al.
Publicado: (2022) -
Structural insights into sGC
por: Akker, Focco van den, et al.
Publicado: (2009)